GlassScriptPhysician profile
Robert H Pare
NPI 1205865490
$1,195.31
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $757 · 2020: $215 · 2021: $205 · 2022: $18.24.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $426.89 | 2019-2021 | |
| Exeltis, USA INC. | $111.57 | 2019-2021 | |
| Hologic Sales and Service, LLC | $86.84 | 2019-2021 | |
| Therapeuticsmd, INC. | $74.97 | 2019 | |
| Pfizer INC. | $69.95 | 2019-2020 | |
| Kvk-Tech, INC. | $56.82 | 2019-2021 | |
| Millicent US INC | $48.61 | 2019-2020 | |
| Mylan Pharmaceuticals INC. | $42.30 | 2019 | |
| Duchesnay USA Incorporated | $39.77 | 2019 | |
| Vivus LLC | $31.78 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $29.87 | 2019-2021 | |
| Amgen INC. | $29.77 | 2019-2020 | |
| Avion Pharmaceuticals | $25.42 | 2019 | |
| Allergan, INC. | $24.87 | 2019-2020 | |
| Coloplast Corp | $20.05 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $18.24 | 2022 | |
| Vertical Pharmaceuticals, LLC | $16.94 | 2019 | |
| Coopersurgical, INC. | $14.83 | 2021 | |
| Aspira Women'S Health INC | $13.28 | 2020 | |
| Amag Pharmaceuticals, INC. | $12.54 | 2019 |
1 company reported research payments only; those appear in the research section below.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Pare listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.